feed,title,long_url,short_url
Benzinga,Analysts Slash Price Targets On C3.ai Post Q2 Results,https://benzinga.com/analyst-ratings/analyst-color/21/12/24400545/analysts-slash-price-targets-on-c3-ai-post-q2-results,https://j.mp/3oeotny
Benzinga,FDA Signs Off Chemomab's Lead Candidate Mid-Stage Study In Bile Duct Disease,https://benzinga.com/general/biotech/21/12/24401470/fda-signs-off-chemomabs-lead-candidate-mid-stage-study-in-bile-duct-disease,https://j.mp/3rs5Xdx
